Corcept Therapeutics
Price & Volume
Stats
See more52W Range | $32.33-$117.33 |
Market Cap | $7.5B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $685.4M |
Revenue Growth (YoY) | 7.1% |
Gross Profit (12 Mos) | $674.1M |
Diluted EPS | $1.15 |
News
See moreYahoo Finance • 5 days ago
Corcept Submits NDA For Relacorilant To Treat Platinum-Resistant Ovarian Cancer
Yahoo Finance • 6 days ago
Corcept seeks FDA approval for ovarian cancer treatment
Yahoo Finance • 9 days ago
Piper Sandler reiterates Overweight rating on Corcept Therapeutics stock
Yahoo Finance • 16 days ago
Corcept therapeutics officer Guyer sells $7350 in shares
About
CEO | Dr. Joseph K. Belanoff M.D. |
CFO | Mr. Atabak Mokari |
Address | 101 Redwood Shores Parkway, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 500 |
